Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in ORKA — Oruka Therapeutics, Inc.

CIK 1446194 BALA CYNWYD, PA

Position in ORKA

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$1,029,265
+$766,629 QoQ
Shares Held
20,984
+142.2% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2024
6 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in ORKA Over Time

Shares Held

Position Value (USD)

Derivatives in ORKA

reported options exposure · as of Mar 31, 2026
CallValue
$1,442,070
CallShares
29,400
PutValue
$971,190
PutShares
19,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,159,899,084 across 353 Biotechnology names. ORKA ranks #165 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ORKA

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $971,190 19,800
2026-03-31 $1,442,070 29,400
2026-03-31 $1,029,265 20,984
2025-12-31 $521,332 17,200
2025-12-31 $445,557 14,700
2025-12-31 $262,636 8,665
2025-09-30 $1,396,098 72,600
2025-09-30 $248,067 12,900
2025-06-30 $380,714 33,962
2025-03-31 $3,591,369 350,036
2024-09-30 $306,375 12,500